The Only End-to-End Commercialisation Partner

Predictable Commercial Success When Commercialising in the U.S.

Today’s global pharmaceutical industry is evolving into uncharted territories. Opportunities in drug pricing, access, reimbursement, adherence and product delivery shift every day, and you need agile solutions to keep up with new market challenges.

Now you don’t have to face the unknowns of commercialisation alone. EVERSANA offers custom solutions for your product, patients and other key stakeholders.

Learn more about our EVERSANA COMPLETE Commercialisation model and explore recent partnerships.


Maximising Your Brand’s Value & Success

Launching a product is becoming more difficult in the competitive global market. Companies often spend more than $125MM over three years leading up to launch, and 66% of drugs still fail to meet launch expectations.

We understand that this looming risk and general industry pressures require a more advanced commercialisation option to effectively maximise your pipeline. Imagine not having to risk building an expensive infrastructure on your own — because we’ve already built a customizable commercialisation foundation for your product needs.

As your integrated life sciences partner, we perform as an extension of your team and inform decisions that ultimately improve the lives of patients.

EVERSANA is committed to:

  • Delivering more value than traditional licencing or launching on your own.
  • Activating a complete, ready-to-deploy, high-performance commercialisation and distribution engine.
  • Accelerating your product from early development to marketing, effectively impacting patient outcomes and beyond.
  • Lowering the risk and cost of launch.
  • Supporting your launch globally: U.S., Europe and key markets in Asia Pacific.

Contact us to discuss how your product can immediately benefit from the COMPLETE Commercialisation model.